The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults

Summary

This is a Phase 1, open-label, fixed-sequence, 3-period, 2-way drug interaction study designed to assess the pharmacokinetics, pharmacodynamics, safety, and tolerability of LC350189 and Naproxen when administered alone and in combination in healthy subjects.

Timeline

Start

2020-01-22

Primary completion

2020-02-25

Completion

2020-02-25

Drugs

Indications